source
- Anew Labs, ByteDance’s biotech spinout, raises $290M to build a China AI bio rivalAnew Labs, a biotech spinout from ByteDance, announced it has secured $290 million in funding. The capital came from a mix of Chinese investors such as HSG, IDG Capital and Hillhouse Investment, a…
- Vivodyne’s Human Tissue Factory Wins Endpoints 11 2026, Promising Faster Drug TestingVivodyne was announced as the winner of the Endpoints 11 2026 competition for its human tissue factory technology. The platform creates human tissue constructs that can be used in preclinical drug…